TERT accelerates BRAF mutant–induced thyroid cancer dedifferentiation and progression by regulating ribosome biogenesis

TERT reactivation occurs frequently in human malignancies, especially advanced cancers. However, in vivo functions of TERT reactivation in cancer progression and the underlying mechanism are not fully understood. In this study, we expressed TERT and/or active BRAF (BRAF V600E) specifically in mouse thyroid epithelium. While BRAF V600E alone induced papillary thyroid cancer (PTC), coexpression of BRAF V600E and TERT resulted in poorly differentiated thyroid carcinoma (PDTC). Spatial transcriptome analysis revealed that tumors from mice coexpressing BRAF V600E and TERT were highly heterogeneous, and cell dedifferentiation was positively correlated with ribosomal biogenesis. Mechanistically, TERT boosted ribosomal RNA (rRNA) expression and protein synthesis by interacting with multiple proteins involved in ribosomal biogenesis. Furthermore, we found that CX-5461, an rRNA transcription inhibitor, effectively blocked proliferation and induced redifferentiation of thyroid cancer. Thus, TERT promotes thyroid cancer progression by inducing cancer cell dedifferentiation, and ribosome inhibition represents a potential strategy to treat TERT-reactivated cancers.

[1]  Hui Wang,et al.  Personalized Treatment of Advanced Gastric Cancer Guided by the MiniPDX Model , 2022, Journal of oncology.

[2]  Xin Zhang,et al.  OncoVee™-MiniPDX-Guided Anticancer Treatment for Gastric Cancer Patients With Synchronous Liver Metastases: A Retrospective Cohort Analysis , 2022, Frontiers in Oncology.

[3]  Zhenglin Du,et al.  Database Resources of the National Genomics Data Center, China National Center for Bioinformation in 2022 , 2021, Nucleic Acids Res..

[4]  Jiucun Wang,et al.  Single-cell transcriptomic analysis of the tumor ecosystems underlying initiation and progression of papillary thyroid carcinoma , 2021, Nature Communications.

[5]  C. Landen,et al.  CX-5461 Treatment Leads to Cytosolic DNA-Mediated STING Activation in Ovarian Cancer , 2021, Cancers.

[6]  Wenming Zhao,et al.  The Genome Sequence Archive Family: Toward Explosive Data Growth and Diverse Data Types , 2021, bioRxiv.

[7]  Z. Zhou,et al.  Structures of telomerase at several steps of telomere repeat synthesis , 2021, Nature.

[8]  Ben Ma,et al.  ARMS-qPCR Improves Detection Sensitivity of Earlier Diagnosis of Papillary Thyroid Cancers with Worse Prognosis Determined by BRAF V600E and TERT Promoter Co-existing Mutations. , 2021, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[9]  L. Montanaro,et al.  DKC1 Overexpression Induces a More Aggressive Cellular Behavior and Increases Intrinsic Ribosomal Activity in Immortalized Mammary Gland Cells , 2020, Cancers.

[10]  Raphael Gottardo,et al.  Integrated analysis of multimodal single-cell data , 2020, Cell.

[11]  M. Hirokawa,et al.  Indications and strategy for active surveillance of adult low-risk papillary thyroid microcarcinoma: consensus statements from the Japan Association of Endocrine Surgery task force on management for papillary thyroid microcarcinoma. , 2020, Thyroid : official journal of the American Thyroid Association.

[12]  J. Villanueva,et al.  TARGETING TELOMERASE FOR CANCER THERAPY , 2020, Oncogene.

[13]  Michael Biehl,et al.  Tissue- and development-stage–specific mRNA and heterogeneous CNV signatures of human ribosomal proteins in normal and cancer samples , 2020, Nucleic acids research.

[14]  E. Berns,et al.  CX-5461 activates the DNA damage response and demonstrates therapeutic efficacy in high-grade serous ovarian cancer , 2020, Nature Communications.

[15]  J. Doudna,et al.  Cancer-specific loss of TERT activation sensitizes glioblastoma to DNA damage , 2020, Proceedings of the National Academy of Sciences.

[16]  R. DePinho,et al.  Programmable base editing of mutated TERT promoter inhibits brain tumour growth , 2020, Nature Cell Biology.

[17]  Ben S. Wittner,et al.  Deregulation of ribosomal protein expression and translation promotes breast cancer metastasis , 2020, Science.

[18]  D. Fuhrer,et al.  2019 European Thyroid Association Guidelines for the Treatment and Follow-Up of Advanced Radioiodine-Refractory Thyroid Cancer , 2019, European Thyroid Journal.

[19]  Xuan Cheng,et al.  PES1 is a critical component of telomerase assembly and regulates cellular senescence , 2019, Science Advances.

[20]  Jijun Cheng,et al.  Characterization of drug responses of mini patient-derived xenografts in mice for predicting cancer patient clinical therapeutic response , 2018, Cancer communications.

[21]  George Thomas,et al.  Ribosome biogenesis in cancer: new players and therapeutic avenues , 2017, Nature Reviews Cancer.

[22]  Donavan T. Cheng,et al.  Mutational Landscape of Metastatic Cancer Revealed from Prospective Clinical Sequencing of 10,000 Patients , 2017, Nature Medicine.

[23]  Jian Xian,et al.  CX-5461 is a DNA G-quadruplex stabilizer with selective lethality in BRCA1/2 deficient tumours , 2017, Nature Communications.

[24]  Johnathan D. Ebben,et al.  Friend or foe? Telomerase as a pharmacological target in cancer and cardiovascular disease. , 2016, Pharmacological research.

[25]  R. Chernock.  Immunohistochemistry of thyroid gland carcinomas: clinical utility and diagnostic pitfalls , 2016 .

[26]  J. Mesirov,et al.  The Molecular Signatures Database Hallmark Gene Set Collection , 2015 .

[27]  F. He,et al.  hTERT promotes the invasion of gastric cancer cells by enhancing FOXO3a ubiquitination and subsequent ITGB1 upregulation , 2015, Gut.

[28]  Chibo Hong,et al.  The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer , 2015, Science.

[29]  C. Proud,et al.  mTORC1 signaling controls multiple steps in ribosome biogenesis. , 2014, Seminars in cell & developmental biology.

[30]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[31]  Steven J. M. Jones,et al.  Integrated Genomic Characterization of Papillary Thyroid Carcinoma , 2014, Cell.

[32]  Jitendra Kumar Meena,et al.  Telomerase stimulates ribosomal DNA transcription under hyperproliferative conditions , 2014, Nature Communications.

[33]  Grzegorz Kudla,et al.  A pre-ribosomal RNA interaction network involving snoRNAs and the Rok1 helicase , 2014, RNA.

[34]  T. Jacks,et al.  p53 constrains progression to anaplastic thyroid carcinoma in a Braf-mutant mouse model of papillary thyroid cancer , 2014, Proceedings of the National Academy of Sciences.

[35]  M. Buszczak,et al.  Changes in rRNA Transcription Influence Proliferation and Cell Fate Within a Stem Cell Lineage , 2014, Science.

[36]  B. Mitchell,et al.  Akt activation enhances ribosomal RNA synthesis through casein kinase II and TIF-IA , 2013, Proceedings of the National Academy of Sciences.

[37]  M. Ruden,et al.  Novel anticancer therapeutics targeting telomerase. , 2013, Cancer treatment reviews.

[38]  T. Chan,et al.  Frequent somatic TERT promoter mutations in thyroid cancer: higher prevalence in advanced forms of the disease. , 2013, The Journal of clinical endocrinology and metabolism.

[39]  N. Besic,et al.  Sites of metastases of anaplastic thyroid carcinoma: autopsy findings in 45 cases from a single institution. , 2013, Thyroid : official journal of the American Thyroid Association.

[40]  Sridhar Ramaswamy,et al.  Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells , 2012, Nucleic Acids Res..

[41]  E. Liu,et al.  Telomerase directly regulates NF-κB-dependent transcription , 2012, Nature Cell Biology.

[42]  Adam Siddiqui-Jain,et al.  Discovery of CX-5461, the First Direct and Selective Inhibitor of RNA Polymerase I, for Cancer Therapeutics. , 2012, ACS medicinal chemistry letters.

[43]  Gerald C. Chu,et al.  Telomerase Reactivation following Telomere Dysfunction Yields Murine Prostate Tumors with Bone Metastases , 2012, Cell.

[44]  Helga Thorvaldsdóttir,et al.  Molecular signatures database (MSigDB) 3.0 , 2011, Bioinform..

[45]  T. Giordano,et al.  Progression of BRAF-induced thyroid cancer is associated with epithelial-mesenchymal transition requiring concomitant MAP kinase and TGFβ signaling , 2011, Oncogene.

[46]  S. Mandel,et al.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. , 2009, Thyroid : official journal of the American Thyroid Association.

[47]  Philippe Pierre,et al.  SUnSET, a nonradioactive method to monitor protein synthesis , 2009, Nature Methods.

[48]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[49]  L. Lau,et al.  Physical and functional interaction between Pes1 and Bop1 in mammalian ribosome biogenesis. , 2004, Molecules and Cells.

[50]  David A. Band,et al.  Enp1, a yeast protein associated with U3 and U14 snoRNAs, is required for pre-rRNA processing and 40S subunit synthesis. , 2003, Nucleic acids research.

[51]  Francesco Piazza,et al.  Dyskeratosis Congenita and Cancer in Mice Deficient in Ribosomal RNA Modification , 2003, Science.

[52]  R. Reddel,et al.  Alternative lengthening of telomeres in mammalian cells , 2002, Oncogene.

[53]  M. Blasco,et al.  Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes , 2001, The EMBO journal.

[54]  C. Cheung,et al.  Immunohistochemical Diagnosis of Papillary Thyroid Carcinoma , 2001, Modern Pathology.

[55]  D. V. Von Hoff,et al.  Effect of telomere and telomerase interactive agents on human tumor and normal cell lines. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[56]  N. Rose,et al.  Mouse thyroid primary culture. , 1999, Biochemical and biophysical research communications.

[57]  C B Harley,et al.  Specific association of human telomerase activity with immortal cells and cancer. , 1994, Science.

[58]  Jacob D. Jaffe,et al.  Next-generation characterization of the Cancer Cell Line Encyclopedia , 2019, Nature.

[59]  P. Santisteban,et al.  Thyroid transcription factors in development, differentiation and disease , 2015, Nature Reviews Endocrinology.

[60]  Geoffrey E. Hinton,et al.  Visualizing Data using t-SNE , 2008 .

[61]  M. Voso,et al.  Telomerase activity in human hematopoietic progenitor cells. , 1997, Haematologica.